Flag Therapeutics

Raleigh, United States Founded: 2013 • Age: 13 yrs
Small molecule therapeutics for difficult-to-treat cancers are developed.
Request Access

About Flag Therapeutics

Flag Therapeutics is a company based in Raleigh (United States) founded in 2013.. Flag Therapeutics has raised $1.37 million across 5 funding rounds from investors including HHS and NCBiotech. Flag Therapeutics offers products and services including FLAG-003 and FLAG-094.

  • Headquarter Raleigh, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Flag Therapeutics, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $1.37 M (USD)

    in 5 rounds

  • Latest Funding Round
    $72.5 K (USD), Seed

    Jun 28, 2019

  • Investors
    HHS

    & 1 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Flag Therapeutics

Flag Therapeutics offers a comprehensive portfolio of products and services, including FLAG-003 and FLAG-094. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Small molecule treatment for DIPG and GBM cancers

Small molecule therapy for endometrial ovarian cancer

Funding Insights of Flag Therapeutics

Flag Therapeutics has successfully raised a total of $1.37M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $72.5 thousand completed in June 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round Seed — $72,500
  • First Round

    (06 May 2014)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2019 Amount Seed - Flag Therapeutics Valuation

investors

Jan, 2019 Amount Seed - Flag Therapeutics Valuation

investors

Sep, 2017 Amount Grant - Flag Therapeutics Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Flag Therapeutics

Flag Therapeutics has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS and NCBiotech. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Biotech startups are incubated and funded in North Carolina.
Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Flag Therapeutics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Flag Therapeutics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Flag Therapeutics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Flag Therapeutics

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Flag Therapeutics

Frequently Asked Questions about Flag Therapeutics

When was Flag Therapeutics founded?

Flag Therapeutics was founded in 2013 and raised its 1st funding round 1 year after it was founded.

Where is Flag Therapeutics located?

Flag Therapeutics is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.

Is Flag Therapeutics a funded company?

Flag Therapeutics is a funded company, having raised a total of $1.37M across 5 funding rounds to date. The company's 1st funding round was a Grant of $1.5M, raised on May 06, 2014.

What does Flag Therapeutics do?

Flag Therapeutics was founded in 2013 in Raleigh, United States, within the biotechnology sector focused on oncology. Small molecule therapeutics are developed using a proprietary platform that produces water-soluble compounds designed to target and bind cancer cells. The pipeline includes FLAG-003, a lead candidate for treating Diffuse Intrinsic Pontine Glioma and glioblastoma multiforme, addressing unmet needs in difficult cancers.

What products or services does Flag Therapeutics offer?

Flag Therapeutics offers FLAG-003 and FLAG-094.

Who are Flag Therapeutics's investors?

Flag Therapeutics has 2 investors. Key investors include HHS, and NCBiotech.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available